MMB Healthcare pharmaceutical group companies are a network of independent associated companies focused on improving patient health and addressing unmet medical needs primarily by acquiring, developing, manufacturing and commercializing specialty pharmaceutical products in niche orphan disease and specialty market segments.

Group pharmaceutical companies include West Therapeutic Development, LLC (Northbrook, IL), BTCP Pharma, LLC (Cody, WY), Oprems, LLC - Technology/Software (Cody, WY), Lincoln Therapeutics, LLC (Grand Forks, ND) and Eolas Pharma Teoranta and Elefsee Pharmaceuticals International, LTD which are located at Udaras Na Gaeltacha, Na Forbacha Galway Ireland.

We create new healthcare companies through acquisitions, primarily in the pharmaceutical segment, which includes branded drugs, biologics, biosimilars and generics, then pursue organic growth to create value.


Biopharmaceutical Companies

SLAN Medicinal
West Therapeutic Development
Lincoln Therapeutics

Mr. Burke serves as the controlling shareholder and/or Chairman of the Board of Eolas Pharma Teoranta, West Therapeutic Development, LLC, Buckeye Pharmaceuticals, LLC and BTCP Pharma.

Prior to founding MMB Healthcare Investments, Mr. Burke was one of three founding investors and an operating executive at Marathon Pharmaceuticals, LLC, a specialty pharmaceutical company that acquired, developed, grew and then divested specialty and orphan disease pharmaceutical products.

Prior to Marathon, Mr. Burke was one of the first members of the Ovation Pharmaceuticals’ executive team. As an operating executive he focused on sales, marketing, business development and the assessment of acquisition targets. In 2008, he was named one of the “45 under 45 Emerging Pharma Leaders” by Pharmaceutical Executive. He became chief commercial officer of Lundbeck Inc. following Lundbeck’s acquisition of Ovation in 2009.

Prior to Ovation, Mr. Burke spent eight years in the Pharmaceuticals Products Division at Abbott Laboratories, where he served in various sales and marketing roles and managed specialty market and primary care product lines.

Mr. Burke holds a B.A. from Providence College and an M.B.A. from the Kellogg School of Management at Northwestern University.

Mr. Burke serves as an Executive Board Member of the MMB Healthcare network of independent associated healthcare companies. In this role he provides insight and counsel on mergers and acquisitions as well as directing corporate financing strategy for the various companies.

Mr. Burke is an accomplished finance executive with over 25 years of experience in the real estate, principal investment, private equity, fixed income and investment banking sectors, primarily with Lehman Brothers, Dresdner Kleinwort and Wachovia Securities International, with the last 16 years in London and the prior 10 years in New York.

Mr. Burke has successfully operated in both principal and advisory roles in multiple international jurisdictions. He has completed equity and debt transactions in the real estate; mortgage; infrastructure; sports and media; asset backed operating company sectors raising, financing or investing more than $15 billion in over 50 transactions.

Mr. Burke received a B.A. from Georgetown University in 1988 and an MBA in finance from Columbia University in 1993.

Mr. Burke is based in London.

Mr. Borgerding serves as the Vice President, General Counsel & Chief Compliance Officer at the MMB Healthcare network of independent associated healthcare companies.

Prior to MMB Healthcare, Mr. Borgerding served as Vice President, Legal Affairs & Chief Compliance Officer with Assertio Therapeutics, Inc. Prior to Assertio, he was with Lundbeck in legal roles of increasing responsibility including as Vice President, Chief Compliance Officer and Corporate Counsel. Prior to Lundbeck, he was a Senior Counsel at Takeda Pharmaceuticals North America, an Associate at K&L Gates in Washington, DC, and a Regulatory Counsel at the Food and Drug Administration. Mr. Borgerding served with the U.S. Army’s 82nd Airborne Division and deployed in support of Operation Iraqi Freedom in 2003.

Mr. Borgerding earned his J.D. from Valparaiso University School of Law and his BA in Biological Sciences from DePauw University.